Payment overview · 2025
General Payments
$113.31
5 reported records · 2 companies
Healthcare provider profile · identity verified
Edward B. Stolyar, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · BROOKLYN, NY · NPI 1548236417
Verified facts
What the public records show
CMS Open Payments records show Edward B. Stolyar, D.O. received $113.31 in general payments during 2025 across 5 reported records.
Amgen Inc. accounted for 83.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Prolia by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULANCE as an associated drug or biological on 2652 records involving 1501 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Trulance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $94.02 | 83.0% | 4 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $19.29 | 17.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $113.31 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TEPEZZA Normalized: tepezza |
Biological | Amgen Inc. | $49.41 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $44.61 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $44.61 | 2 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | TRULANCE open payments reported associated product |
CMS Open Payments — General Payments 2652 supporting records · 1501 recipient NPIs · example record 1231775445 |
Trulance · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 839 | 180 |
| Eliquis | Apixaban | 648 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 625 | 132 |
| Mirtazapine | Mirtazapine | 417 | 82 |
| Tamsulosin Hcl | Tamsulosin Hcl | 392 | 84 |
| Furosemide | Furosemide | 381 | 84 |
| Gabapentin | Gabapentin | 351 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 347 | 83 |
| Donepezil Hcl | Donepezil Hcl | 338 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 336 | 111 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 322 | 77 |
| Losartan Potassium | Losartan Potassium | 303 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 254 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 239 | 57 |
| Memantine Hcl | Memantine Hcl | 224 | 33 |
| Januvia | Sitagliptin Phosphate | 209 | 38 |
| Metformin Hcl | Metformin Hcl | 203 | 41 |
| Zenpep | Lipase/Protease/Amylase | 194 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 187 | 56 |
| Labetalol Hcl | Labetalol Hcl | 175 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 171 | 34 |
| Lactulose | Lactulose | 170 | 46 |
| Nifedipine Er | Nifedipine | 162 | 34 |
| Sertraline Hcl | Sertraline Hcl | 157 | 25 |
| Carvedilol | Carvedilol | 147 | 33 |
| Famotidine | Famotidine | 147 | 41 |
| Jardiance | Empagliflozin | 147 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 144 | 42 |
| Levetiracetam | Levetiracetam | 126 | 18 |
| Lisinopril | Lisinopril | 124 | 21 |
| Finasteride | Finasteride | 113 | 24 |
| Lorazepam | Lorazepam | 111 | 12 |
| Omeprazole | Omeprazole | 106 | 34 |
| Mupirocin | Mupirocin | 94 | 43 |
| Telmisartan | Telmisartan | 90 | 13 |
| Latanoprost | Latanoprost | 87 | 23 |
| Tradjenta | Linagliptin | 86 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 85 | 12 |
| Alprazolam | Alprazolam | 84 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 84 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 84 | 23 |
| Risperidone | Risperidone | 79 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 77 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 76 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 76 | 19 |
| Trazodone Hcl | Trazodone Hcl | 74 | 18 |
| Vascepa | Icosapent Ethyl | 73 | 18 |
| Entresto | Sacubitril/Valsartan | 72 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 23 |
| Icosapent Ethyl | Icosapent Ethyl | 67 | 14 |
| Montelukast Sodium | Montelukast Sodium | 67 | 15 |
| Mounjaro | Tirzepatide | 66 | 13 |
| Baclofen | Baclofen | 63 | 13 |
| Linzess | Linaclotide | 63 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 63 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 60 | 11 |
| Allopurinol | Allopurinol | 58 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 58 | 18 |
| Simvastatin | Simvastatin | 58 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 57 | suppressed |
| Repaglinide | Repaglinide | 55 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 54 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 52 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 52 | 14 |
| Warfarin Sodium | Warfarin Sodium | 52 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 51 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 51 | 18 |
| Xarelto | Rivaroxaban | 51 | 13 |
| Potassium Chloride | Potassium Chloride | 50 | 11 |
| Prednisone | Prednisone | 50 | 21 |
| Spironolactone | Spironolactone | 50 | 12 |
| Ammonium Lactate | Ammonium Lactate | 49 | 15 |
| Ezetimibe | Ezetimibe | 49 | 12 |
| Ranolazine Er | Ranolazine | 49 | 11 |
| Myrbetriq | Mirabegron | 48 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 46 | 21 |
| Midodrine Hcl | Midodrine Hcl | 45 | 15 |
| Sodium Chloride | 0.9 % Sodium Chloride | 45 | 16 |
| Clonidine | Clonidine | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 43 | 18 |
| Atenolol | Atenolol | 40 | suppressed |
| Ozempic | Semaglutide | 40 | suppressed |
| Synthroid | Levothyroxine Sodium | 40 | suppressed |
| Dutasteride | Dutasteride | 39 | 11 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 39 | 15 |
| Sucralfate | Sucralfate | 39 | 15 |
| Aripiprazole | Aripiprazole | 38 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 37 | 18 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 36 | 12 |
| Tramadol Hcl | Tramadol Hcl | 36 | 27 |
| Trulicity | Dulaglutide | 36 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Nystatin | Nystatin | 32 | 15 |
| Santyl | Collagenase Clostridium Hist. | 32 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 31 | suppressed |
| Digoxin | Digoxin | 31 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 31 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 30 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Celecoxib | Celecoxib | 29 | 15 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 18 |
| Heparin Sodium | Heparin Sodium,porcine | 28 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | 13 |
| Clozapine | Clozapine | 27 | suppressed |
| Insulin Lispro | Insulin Lispro | 27 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 27 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 14 |
| Ceftriaxone | Ceftriaxone Sodium | 26 | 19 |
| Lurasidone Hcl | Lurasidone Hcl | 26 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 25 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 25 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Repatha Sureclick | Evolocumab | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 20 | suppressed |
| Modafinil | Modafinil | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 11 |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 19 | 11 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 18 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 17 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Cyclosporine | Cyclosporine | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 17 | suppressed |
| Trulance | Plecanatide | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 16 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 13 |
| Dapagliflozin | Dapagliflozin Propanediol | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | 11 |
| Azithromycin | Azithromycin | 15 | 14 |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Exemestane | Exemestane | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 13 |
| Fluconazole | Fluconazole | 14 | 11 |
| Glimepiride | Glimepiride | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Procto-Med Hc | Hydrocortisone | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 11 |
| Penicillin V Potassium | Penicillin V Potassium | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Meloxicam | Meloxicam | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Prolia | Denosumab | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $113.31 · 5 records | Amgen Inc. | OTEZLA, REPATHA, TEPEZZA, XIFAXAN | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error